Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More
1 minute read

Reported Late Wednesday, FP Credit Partners II, L.P. And FP Credit Partners Phoenix II, L.P. Announce Termination Of Pathfinder Acquisition Corporation Tender Offer To Purchase Up To An Aggregate Of $75M Of Class A Ordinary Shares

By Benzinga Newsdesk
January 5, 1:38 AM
FP Credit Partners II, L.P. ("FPCP") and FP Credit Partners Phoenix II, L.P. ("FPCPP" and together with FPCP, the "Purchasers") today announced that they have terminated their previously

PFDR

Read More
2 minute read

Reported Late Wednesday, WuXi Biologics And GSK Enter Into License Agreement On Multiple Novel Bi- & Multi-specific T Cell Engagers; Wuxi Biologics Will Receive An Upfront Payment Of $40M And Tiered Royalties On Net Sales

By Benzinga Newsdesk
January 5, 1:36 AM
WuXi Biologics will provide an exclusive license to GSK for one preclinical bi-specific T cell engaging (TCE) antibody and the option of three additional bi-/multi-specific TCE antibodies developed using WuXi

GSK